In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The closing price of Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) was $40.45 for the day, up 6.28% from the previous closing price of $38.06. In other words, the price has increased by $6.28 from its previous closing price. On the day, 0.92 million shares were traded.
Ratios:
Our analysis of TNXP’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 11.64 and its Current Ratio is at 12.31. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On April 18, 2019, ROTH Capital Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $4.
ROTH Capital Upgraded its Neutral to Buy on August 18, 2017, while the target price for the stock was maintained at $6.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 15 ’25 when LEDERMAN SETH bought 4,000 shares for $21.55 per share. The transaction valued at 86,200 led to the insider holds 4,005 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 29.51 while its Price-to-Book (P/B) ratio in mrq is 1.54.
Stock Price History:
Over the past 52 weeks, TNXP has reached a high of $549.12, while it has fallen to a 52-week low of $6.76. The 50-Day Moving Average of the stock is 78.72%, while the 200-Day Moving Average is calculated to be 90.30%.
Shares Statistics:
A total of 7.32M shares are outstanding, with a floating share count of 7.32M. Insiders hold about 0.07% of the company’s shares, while institutions hold 6.61% stake in the company.
